Report Code: 12447 | Available Format: PDF
The global endoprosthesis market size stood at around $23,611.4 million in 2021, and it will grow at a CAGR of 12.1% during 2021–2030, to reach $65,997.9 million. The worldwide market is driven by an increase in the frequency of peripheral vascular diseases and orthopedic illnesses. Furthermore, a rise in the patient knowledge regarding the use of prostheses for orthopedic injuries, as well as an increase in the frequency of knee and hip osteoarthritis among the senior population, is expected to boost the worldwide market during the forecast period.
North America dominated the market with around $8.0 billion revenue in 2021, and it is expected to continue doing so in the coming years, owing to the increasing adoption of technically advanced healthcare products in the region. Furthermore, the U.S. accounted for the larger endoprosthesis market share in 2021 in North America. The major factor driving the growth of the market in the country is the rise in the prevalence of knee and hip osteoarthritis among the geriatric population. Nearly one million total hip and knee replacement procedures are performed in the country each year.
During the COVID-19 pandemic, governments were focusing on directing healthcare resources to only essential services. Thus, starting in March 2020, surgeons were asked to perform only the indispensable surgical procedures. The vast majority of arthroplasty surgeries, including endoprosthesis treatments, are not essential, which led to most of them being canceled across the globe.
The knee category held the largest market share in 2021, and it is projected to grow at a significant CAGR, of around 13%, during 2021–2030, based on product type. Knee osteoarthritis is one of the major causes of disability among the elderly. In recent years, knee replacement surgery has become rapidly popular due to the increasing access to orthopedic care in emerging markets, such as APAC. Moreover, according to a recent study, the pooled global prevalence of knee osteoarthritis was 16.0% in individuals aged 15 and over and 22.9% in individuals aged 40 and over.
Moreover, endoprosthesis hip held over 20% endoprosthesis market share in 2021. This category is expected to grow due to the rising prevalence of hip osteoarthritis among the aged population and the surging demand for personalized implants among both men and women. Implant sizes vary since each patient has a unique anatomy. Thus, many firms are focused on 3D printing technologies for patient-specific implants.
The primary knee replacement category held the major share, around 40%, in 2021, and it is expected to grow at a fast pace. To replace a damaged or worn-out knee joint, primary knee replacement surgery employs implants composed of metal, high-density polyethylene, or ceramics.
In the process, the injured thighbone, shinbone, and kneecap or the cartilages are removed and then, replaced with an artificial joint. People undergo primary knee replacement surgery as it makes it easy for them to engage in day-to-day activities. Moreover, osteoporosis and other musculoskeletal disorders can all be managed with this, as strong knees provide better stability and support, thus decreasing the likelihood of falling.
Asia-Pacific accounted for a market size of over $5.0 billion in 2021, which is expected to exhibit a lucrative CAGR of over 13%. This will be owing to the fact that over the next 50 years, there will likely be a significant increase in the number of older people.
The region's healthcare infrastructure has also received a lot of attention in recent years, which fuels the market advance even more. Hence, the region's market growth would be boosted by the rising healthcare spending and the number of hospitals.
In addition, China performs more than 50,000 knee and hip arthroplasties each year. Due to the increasing frequency of orthopedic injuries and diseases among the nation's elderly population, this number is predicted to rise significantly over the next few years. In contrast to industrialized nations, China's endoprosthesis market size is still small, which is creating a considerable opportunity for the players to grow. Over the forecast period, the rising prevalence of osteoarthritis and a rapidly aging population are expected to drive the market expansion in the nation.
Numerous orthopedic procedures, including those on the joints, femur, and other parts, use endoprosthesis. The growing number of elderly people with orthopedic conditions, such as osteoarthritis, is one of the main factors fueling the market's expansion.
For instance, osteoarthritis, which manifests in many body parts, is common among the aging population. The population of people 65 and over in 2020 was 727 million, and by 2050, that figure is expected to quadruple to 1.5 billion, according to the World PopulationAgeing 2020. The burden of orthopedic problems is therefore expected to increase in the coming years, thus contributing to the market growth.
In addition, the World Health Organization lists osteoarthritis and degenerative joint disease as two of the ten most incapacitating diseases in many developing nations. Asymptomatic osteoarthritis is thought to affect 9.6% of the men and 18.0% of the women aged 60 and beyond. Further, 80% of the people with osteoarthritis have mobility restrictions, and 25% are unable to perform most of their regular tasks. The need for endoprostheses, to treat this and other such conditions, is expected to rise as a result of these considerations.
Report Attribute | Details |
Historical Years |
2017-2021 |
Forecast Years |
2022-2030 |
Market Size in 2021 |
$23,611.4 Million |
Revenue Forecast in 2030 |
$65,997.9 Million |
Growth Rate |
12.1% CAGR |
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Segmentation Analysis of Countries; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
Segments Covered |
By Product; By End User; By Region |
Explore more about this report - Request free sample
Major players operating in the market have been involved in several strategic developments, such as product launches and acquisitions, to remain competitive. For instance:
In April 2022, Medacta International SA announced the successful completion of the first lumbar fusion procedure in the U.S. utilizing the M.U.S.T Pedicle Screw System, in combination with NextAR Spine, an AR-based surgical application with intraoperative guidance in spine surgery with the CE mark and FDA cleareance.
In August 2021, Exactech Inc. expanded ts Truliant total knee system with the addition of a new porous-coated implant option. With the Truliant Porous Knee, the company enhanced its platform of advanced material science. The new solution mimics the trabecular nature of cancellous bone with optimal porosity and pore size.
The study offers a comprehensive market segmentation analysis along with market estimation for the period 2017-2030.
Based on Product Type
Based on End User
Regional Analysis
In 2021, the market for endoprosthesis will value $ 23,611.4 million.
Knee prosthesis dominates the endoprosthesis industry.
The market for endoprosthesis will grow the fastest in APAC.
The endoprosthesis industry was negatively affected by COVID-19.
Emerging markets and the growing geriatric population offer opportunities to the players in the market for endoprosthesis.
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws